18F-fluorodeoxyglucose positron emission tomography predicts survival of patients with neuroendocrine tumors

396 Citations (Scopus)

Abstract

(18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) is currently not used on a routine basis for imaging of neuroendocrine (NE) tumors. The aim of this study was to investigate the prognostic value of FDG-PET in patients with NE tumors.
Original languageEnglish
JournalClinical Cancer Research
Volume16
Issue number3
Pages (from-to)978-85
Number of pages8
ISSN1078-0432
DOIs
Publication statusPublished - 1 Feb 2010

Fingerprint

Dive into the research topics of '18F-fluorodeoxyglucose positron emission tomography predicts survival of patients with neuroendocrine tumors'. Together they form a unique fingerprint.

Cite this